Motion Capture Quantification of User Variation in Topical Microparticle Application
暂无分享,去创建一个
Surya P. N. Singh | Tarl W. Prow | Miko Yamada | Aaron J. Snoswell | Giles T. S. Kirby | Aaron Snoswell | T. Prow | Miko Yamada | G. T. Kirby
[1] T. Prow,et al. Physical drug delivery enhancement for aged skin, UV damaged skin and skin cancer: Translation and commercialization. , 2020, Advanced drug delivery reviews.
[2] Yousuf H. Mohammed,et al. Advances and controversies in studying sunscreen delivery and toxicity. , 2020, Advanced drug delivery reviews.
[3] A. Feizpour,et al. Imaging and quantifying drug delivery in skin - Part 1: Autoradiography and mass spectrometry imaging. , 2019, Advanced drug delivery reviews.
[4] Yousuf H. Mohammed,et al. Using elongated microparticles to enhance tailorable nanoemulsion delivery in excised human skin and volunteers , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[5] R. Boukherroub,et al. Heat: A Highly Efficient Skin Enhancer for Transdermal Drug Delivery , 2018, Front. Bioeng. Biotechnol..
[6] R. Neubert,et al. Dermal and transdermal delivery of pharmaceutically relevant macromolecules , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] J. Rivers,et al. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses. , 2016, Skin therapy letter.
[8] M. Bentley,et al. Chemical penetration enhancers. , 2015, Therapeutic delivery.
[9] J. Simon,et al. A prospective randomized exploratory study comparing the efficacy of once‐daily topical 0.5% 5‐fluorouracil in combination with 10.0% salicylic acid (5‐FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[10] T. Prow,et al. Enhanced delivery of nano- and submicron particles using elongated microparticles. , 2015, Current drug delivery.
[11] Richard H Guy,et al. Transdermal drug delivery: 30+ years of war and still fighting! , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[12] H. Soyer,et al. High Aspect Ratio Elongated Microparticles for Enhanced Topical Drug Delivery in Human Volunteers , 2014, Advanced healthcare materials.
[13] H. Wulf,et al. Application of sunscreen − theory and reality , 2014, Photodermatology, photoimmunology & photomedicine.
[14] H. Soyer,et al. Elongate microparticles for enhanced drug delivery to ex vivo and in vivo pig skin. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[15] J. Etzkorn,et al. Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[16] H. Maibach,et al. Interindividual variation in transdermal and oral drug deliveries. , 2012, Journal of pharmaceutical sciences.
[17] H. Kerl,et al. Low‐dose 5‐fluorouracil in combination with salicylic acid as a new lesion‐directed option to treat topically actinic keratoses: histological and clinical study results , 2011, The British journal of dermatology.
[18] A. Morris,et al. Performance of transdermal therapeutic systems: Effects of biological factors , 2011, International journal of pharmaceutical investigation.
[19] S. Culine,et al. Inter- and Intraindividual Variabilities in Pharmacokinetics of Fentanyl After Repeated 72-Hour Transdermal Applications in Cancer Pain Patients , 2005, Therapeutic drug monitoring.
[20] C. Schlagel,et al. THE WEIGHTS OF TOPICAL PREPARATIONS REQUIRED FOR TOTAL AND PARTIAL BODY INUNCTION. , 1964, Journal of Investigative Dermatology.